FDA Commissioner Scott Gottlieb's resignation comes as a shock to many. "I see this is a big loss for the administration's efforts to address drug pricing," CP3 Director Walid Gellad told BioPharma Dive.
FDA Commissioner Scott Gottlieb's resignation comes as a shock to many. "I see this is a big loss for the administration's efforts to address drug pricing," CP3 Director Walid Gellad told BioPharma Dive.